Our findings provided evidence that S100A9 silencing inhibited the release of inflammatory cytokines, suppressed the proliferation and promoted apoptosis of pancreatic cells in a mouse model of AP, via the blockade of the IL‐17 signalling pathway, thus highlighting the potential of S100A9 as a therapy target in the treatment of AP. Here, S100A9 is linked to alkaline phosphatase measurement.